These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23286437)

  • 1. Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives.
    Moutzouri E; Tsimihodimos V; Tselepis AD
    Curr Pharm Des; 2013; 19(21):3827-40. PubMed ID: 23286437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction.
    Sudhir K
    Vasc Health Risk Manag; 2006; 2(2):153-6. PubMed ID: 17319459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
    Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
    J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.
    Sudhir K
    J Clin Endocrinol Metab; 2005 May; 90(5):3100-5. PubMed ID: 15713711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lp-PLA2 and sPLA2: cardiovascular biomarkers].
    Ait-Oufella H; Mallat Z; Tedgui A
    Med Sci (Paris); 2014 May; 30(5):526-31. PubMed ID: 24939539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.
    Garza CA; Montori VM; McConnell JP; Somers VK; Kullo IJ; Lopez-Jimenez F
    Mayo Clin Proc; 2007 Feb; 82(2):159-65. PubMed ID: 17290721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
    Carlquist JF; Muhlestein JB; Anderson JL
    Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia.
    Güngör ZB; Tüten A; Ekmekçi H; Ekmekçi ÖB; Kucur M; Öncül M; Donma O; Madazlı R; Sönmez H
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3119-3127. PubMed ID: 28784006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study.
    Mattsson N; Magnussen CG; Rönnemaa T; Mallat Z; Benessiano J; Jula A; Taittonen L; Kähönen M; Juonala M; Viikari JS; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1861-6. PubMed ID: 20539018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.
    Koenig W; Twardella D; Brenner H; Rothenbacher D
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1586-93. PubMed ID: 16627803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study.
    Wägner AM; Sánchez-Quesada JL; Benítez S; Bancells C; Ordóñez-Llanos J; Pérez A
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e25-8. PubMed ID: 21440948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
    Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
    Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
    Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
    Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A
    Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L
    Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in Inflammatory Markers and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) Study.
    Lu Y; Zhou S; Dreyer RP; Spatz ES; Geda M; Lorenze NP; D'Onofrio G; Lichtman JH; Spertus JA; Ridker PM; Krumholz HM
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):e003470. PubMed ID: 28228461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.